🌏#activist #GSK #INVA
Elliott Management bought a large stake in GlaxoSmithKline - rumors

Want to encourage #GSK to invest more in R&D

⚠️🇺🇸#pharmaceutical #HIK #INVA
FDA takes approval generic version of Advair by Hikma Pharmaceuticals

⚠️🇺🇸#pharmaceutical #TEVA #INVA
28/01/2021 European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Seffalair Spiromax (generic version of Advair) by TEVA

#INVA #insider #offer #watchlist
Innoviva will buy back its stake from GlaxoSmithKline #GSK at $12.25 per share

🇬🇧#GSK #INVA #insider
The government is concerned about a potential takeover of GlaxoSmithKline in the wake of investment by an American #activist Elliott Management and has asked officials to monitor the situation amid concerns about the forced sale of the whole group, its pharmaceutical or vaccine business. - The Times

Elliott Management met with other GlaxoSmithKline investors and told them that "a change is coming."

🇺🇸#INVA #watchlist
Innoviva invested $45M in biotech startup Armata Pharmaceuticals #ARMP